💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Walgreens profit beats expectations; more cost cuts planned

Published 04/09/2015, 11:10 AM
© Reuters. People walk by a Walgreens store in Pasadena
WBA
-

By Nandita Bose and Shailaja Sharma

(Reuters) - Drugstore operator Walgreens Boots Alliance Inc (O:WBA) on Thursday reported a higher-than-expected quarterly profit and said it would widen its cost-cutting program, sending its shares higher.

The company, formed by the December acquisition of Europe's Alliance Boots by Walgreen Co , said it would reorganize corporate and field operations, streamline information technology functions and close 200 U.S. stores while opening 200 others.

"This really is just getting the right stores in the right place," Executive Vice President Alex Gourlay said on a conference call.

In August, Walgreen Co announced a $1 billion cost-cutting program over three years. Walgreens said on Thursday that it had identified ways to increase the program to a projected $1.5 billion by the August year-end of fiscal 2017.

The company said it would take pretax restructuring charges of $1.6 billion to $1.8 billion over time.

Shares of the largest U.S. drugstore chain operator, which is reporting its first results since the merger, were up 2.8 percent at $90.17.

Walgreens said combined net savings for the first half of fiscal 2015 were $310 million and that it was on track to reach at least $650 million for the full year and $1.0 billion in fiscal 2016.

The company reported a 35.5 percent rise in net sales to $26.6 billion for the second quarter ended Feb. 28, mainly due to the addition of Boots.

Analysts on average had expected sales of $27.77 billion, according to Thomson Reuters I/B/E/S.

Sales at U.S. Walgreens and Duane Reade stores open at least a year rose 6.9 percent, benefiting from a strong cough, cold and flu season and continued growth in Medicare Part D prescriptions.

The U.S. drugstore business generated about 79 percent, or $21 billion, of total sales. Pharmacy sales accounted for 64.4 percent of U.S. sales.

Comparable-store sales in the international retail pharmacy division rose 2.9 percent in January and February.

Net income attributable to Walgreens Boots was $2.04 billion, or $1.93 per share. Walgreen alone earned $716 million, or 74 cents per share, in the year-earlier period.

Excluding special items, Walgreens Boots earned $1.18 per share, beating the analysts' average estimate of 95 cents.

© Reuters. People walk by a Walgreens store in Pasadena

The company forecast full-year earnings of $3.45 to $3.65 per share, excluding items. Analysts were expecting $3.61.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.